Bioline Rx's total assets for Q2 2025 were $43.27M, a decrease of -0.56% from the previous quarter. IL:BLRX total liabilities were $23.20M for the fiscal quarter, a 2.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.